| イスラエル | トルコ | オーストリア | |
| 小線源治療 | から $14,200 | から $3,465 | から $15,000 |
| 子宮頸部円錐切除術 | から $3,200 | から $1,200 | から $2,800 |
| 子宮摘出術 | から $14,500 | から $4,760 | から $15,000 |
| 乳癌化学療法 | から $22,500 | から $1,200 | から $15,000 |
| ダヴィンチロボット支援下子宮摘出術 | から $18,500 | から $11,000 | から $16,000 |
メリムスキー教授はスーラスキー医療センターの腫瘍科を統括し、子宮頸癌を専門として41年の経験にわたる豊富な臨床経験を有しています。
Dr. Shira Felder is a senior radiation oncologist. She focuses on gynecologic and urologic cancers. She has advanced expertise in VMAT, IMRT, SBRT, and gynecologic brachytherapy. She delivers precise treatment with fewer side effects.
She heads the Gynecologic Oncology Service at Sheba Medical Center. She is a senior physician in the Radiation Oncology Division. She earned her MD at Hadassah. She completed residency at Sheba and a fellowship in the Radiation Medicine Program at the University of Toronto and Princess Margaret Cancer Centre. She is board-certified in Radiation Oncology. She is a member of ESTRO, the Israeli oncology societies, the CPSO, and the CMA.
Her research covers brachytherapy patient safety. It also includes stereotactic ablative radiotherapy for stage I lung cancer. She has studied treatment delays in cervical cancer. She has examined vitamin D deficiency in oncology patients.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Major cervical cancer surgery in Israel requires a hospital stay of 2 to 7 days. Full rehabilitation typically takes 4 to 8 weeks for baseline activities. Minimally invasive approaches like robotic surgery allow patients to return to daily routines in 2 to 3 weeks.
Bookimed Expert Insight: Data from top Israeli centers shows a clear trend toward specialized gynecologic oncology departments. For instance, Prof. Tamar Sapra at Sourasky Medical Center brings 30+ years of experience to these complex cases. This deep expertise often translates to more precise lymph node dissections, which are critical because patients note that lymph-related swelling can extend recovery by 1 to 2 months.
Patient Consensus: Patients emphasize that while basic mobility returns within a month, it often takes 4 months to feel normal again. Many recommend starting pelvic floor therapy by day 3 to manage post-operative bowel and bladder changes effectively.
Cervical cancer treatment in Israel utilizes a multidisciplinary approach focused on organ preservation and precision. Leading centers like Sourasky Medical Center and Sheba Medical Center offer robotic surgery, advanced brachytherapy, and targeted immunotherapy. These facilities maintain high success rates while prioritizing fertility for younger patients.
Bookimed Expert Insight: While many patients focus on surgery, the integration of 3D-guided brachytherapy at centers like Sheba Medical Center is a critical differentiator. Data shows these centers handle massive volumes, with over 1.8 million patients annually. This high flux ensures surgeons and radiotherapists maintain elite proficiency in complex, nerve-sparing protocols that preserve pelvic function.
Patient Consensus: Patients emphasize the importance of discussing fertility preservation, like egg freezing, immediately upon diagnosis. Many note that preparing for the physical fatigue of combined chemoradiation helps manage the treatment journey more effectively.
Israeli oncology centers preserve fertility through specialized oncofertility protocols combining organ-sparing surgery and advanced reproductive technologies. Early-stage patients may undergo trachelectomy or conization to keep the uterus intact. Modern clinics also offer egg freezing or embryo cryopreservation before starting radiation or chemotherapy.
Bookimed Expert Insight: Data shows a high integration of robotic technology in Israeli oncofertility. Prof. Dan Grisaro at Sourasky Medical Center utilizes endoscopic and robotic platforms for complex cervical surgeries. These minimally invasive approaches often lead to better pelvic health preservation compared to traditional open surgeries. Patients should prioritize centers with JCI accreditation and Newsweek rankings to ensure access to these specific surgical precision tools.
Patient Consensus: Patients emphasize that egg freezing must happen immediately after diagnosis to avoid treatment delays. They note that while trachelectomy allows for future pregnancy, it often requires specialized prenatal care and cesarean delivery due to cervical scarring.
Israel is a global leader in cervical cancer care with JCI-accredited centers like Sourasky Medical Center and Sheba Medical Center. These facilities offer 90% oncology success rates. Patients access advanced treatments like DaVinci robotic surgery, MRI-guided brachytherapy, and fertility-preserving radical trachelectomies from board-certified specialists.
Bookimed Expert Insight: While many focus on surgery, the integration of MRI-guided brachytherapy at Sheba and Sourasky is a major differentiator. Data shows clinics like Sourasky manage over 400,000 patients annually. This high volume allows doctors like Dr. Tamar Sapra to maintain expertise across 30+ years of practice. For international patients, choosing a hospital with an established brachytherapy service is essential for treating advanced or recurrent cervical cases effectively.
Patient Consensus: Patients note it is important to bring original pathology slides for a second opinion. They also emphasize that while costs are higher for non-citizens, the access to multilingual staff and robotic hysterectomies at Hadassah is highly valued.
International patients typically complete a cervical cancer diagnostic work-up in Israel within 5 to 10 business days. Initial treatment often begins within 1 to 2 weeks after arrival. Integrated centers like Sourasky and Sheba use multidisciplinary tumor boards to accelerate planning for complex oncology cases.
Bookimed Expert Insight: Data from Sourasky Medical Center shows a clear efficiency advantage for international patients through VIP fast-track services. While local systems may take longer, these dedicated departments handle up to 400,000 patients annually. They often coordinate pathology revisions and oncologist consultations like Dr. Tamar Sapra's in a single 5-day block. This coordination is critical because it bypasses the standard 2 to 3 week wait times for imaging slots found in smaller regional facilities.
Patient Consensus: Patients note that arriving with existing medical records can shorten the diagnostic phase by nearly a week. They emphasize that while paperwork is fast, you should pre-book radiation slots to avoid local scheduling bottlenecks.
Israel is a primary destination for cervical cancer due to high 5-year survival rates and early access to advanced technology. Research centers like Sheba Medical Center report 95% remission rates. Facilities utilize MRI-guided brachytherapy and robotic surgery to preserve fertility while ensuring precise tumor destruction.
Bookimed Expert Insight: Data shows a high concentration of expertise at Sourasky Medical Center where Dr. Tamar Sapra and Dr. Dan Grisaro collaborate. This facility serves over 400,000 patients annually and maintains JCI accreditation. Patients seeking specific experience should note that senior specialists here often have over 30 years of practice. This volume of cases translates into refined surgical techniques for complex organ-preserving procedures.
Patient Consensus: Patients note that Israeli teams use specialized AI planning to define tumor margins more accurately than some Western trials. They emphasize that the focus on fertility preservation leads to fewer long-term side effects compared to other destinations.
Israel offers cervical cancer patients 71% to 90% survival rates through rapid access to advanced therapies. Specialist centres like Sheba and Sourasky provide robotic-assisted surgery and real-time 3D brachytherapy. Patients benefit from multidisciplinary planning and oncology expertise within JCI-accredited facilities.
Bookimed Expert Insight: Israeli oncology packages show a significant price gap based on technology levels. A basic surgical package at Sourasky Medical Center costs around A$6,700. In contrast, complex radiotherapy bundles at Sheba Medical Center reach approximately A$102,600. This reflects the high cost of advanced VMAT and brachytherapy equipment used for intensive treatment stages.
Patient Consensus: Patients value the fast, coordinated work-up in Israel where they can bundle scans and pathology reviews. English communication is sufficient for consultations, and integrated care teams help clarify surgery versus chemoradiation options.
Patients can preserve their fertility during cervical cancer treatment in Israel through egg freezing, ovarian transposition, or fertility-sparing surgery. Specialists at JCI-accredited centres like Sheba and Sourasky use advanced protocols to protect reproductive health. Options depends on the cancer stage and treatment timeline.
Bookimed Expert Insight: Israeli oncology centres show a strong pattern of integrated care between gynaecologists and fertility specialists. Dr Shira Felder at Sheba Medical Center, for example, specialises in both radiotherapy and gynaecologic oncology. This dual expertise ensures that radiation plans like VMAT or brachytherapy are designed to spare reproductive organs whenever clinically possible.
Patient Consensus: Patients note that asking for fertility referrals early is vital, as pelvic radiation in Israel may cause permanent changes. Experience shows that fertility-sparing surgery depends on early diagnosis and proactive discussions with the surgical team.
Innovative cervical cancer treatments in Israel focus on precision radiation and fertility-preserving surgeries. Leading centres use VMAT radiotherapy and DaVinci robotic systems to improve accuracy. Advanced systemic therapies, including immunotherapy for recurrent cases, are standard at JCI-accredited hospitals in Tel Aviv and Ramat Gan.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky integrate VMAT with brachytherapy for locally advanced cases. Our data shows this combination is a primary reason patients travel here. While basic radiotherapy is common worldwide, these centres use real-time image guidance. This ensures the highest radiation dose hits the tumour while sparing surrounding organs.
Patient Consensus: Patients note that modern planning like VMAT significantly reduces side effects compared to older radiation methods. They suggest asking about radical trachelectomy early if preserving fertility is a priority while in Israel.
Patients can receive a second opinion from Israeli specialists via remote telemedicine. Leading professors provide document reviews of pathology slides and MRI or PET/CT imaging. This process confirms diagnoses and surgical suitabilty for cervical cancer. Official medical reports arrive in English for local Australian GPs to review.
Bookimed Expert Insight: Israeli oncology centres like Sheba and Sourasky employ specialists with extensive North American training. Dr Shira Felder and Dr Dan Grisaro both completed fellowships at the University of Toronto. This shared training background helps Australian doctors easily understand and implement their treatment recommendations locally.
Patient Consensus: Patients note that providing original digital scans rather than just written summaries leads to more concrete advice. These reviews build significant confidence before starting major procedures like robotic hysterectomies in Israel.
Cervical cancer diagnosis in Israel typically involves a clinical exam, biopsy, and advanced imaging. Professional centres often complete the full diagnostic workup within 3 to 5 days. Specialists perform biopsies and PET-CT scans to confirm the stage before starting any treatment.
Bookimed Expert Insight: Israeli oncology centres excel at speed because they house pathology labs and PET-CT scanners on-site. At Sourasky Medical Center, which serves 400,000 patients annually, this integration allows specialists like Dr Tamar Sapra to move from diagnosis to radiotherapy planning in days rather than weeks.
Patient Consensus: Patients note the process usually follows a set path from initial screening and colposcopy to final staging scans in Israel. They emphasize that while waiting for biopsy results is stressful, the thorough PET-CT staging provides much-needed clarity before surgery.
Recovery times for cervical cancer treatment in Israel vary by procedure. Minor procedures like cervix conisation take 1 to 3 weeks. Major surgeries, including robotic hysterectomies at JCI-accredited centres like Sheba Medical Center, generally require 6 to 8 weeks for full functional healing.
Bookimed Expert Insight: While many centres focus on the procedure, Sheba Medical Center packages suggest a 21-day hotel stay. This reflects the reality of managed recovery. Australian patients should prioritise clinics that build in these long-term recovery windows to handle late-onset radiotherapy side effects.
Patient Consensus: Patients note that fatigue is the most persistent hurdle when returning to work. Australian patients find that recovery is non-linear, so they suggest avoiding tight travel schedules after intensive chemo-radiation.
Leading Israeli oncology hospitals include Sheba Medical Center, Sourasky (Ichilov), and Hadassah Medical Center. These JCI-accredited tertiary centres specialise in complex cervical cancer treatments, including brachytherapy and robotic-assisted surgeries. They integrate clinical trials and multidisciplinary care to achieve success rates reaching 90% for oncology cases.
Bookimed Expert Insight: Israeli oncology centres excel in high-volume, complex cases. For instance, Sheba Medical Center serves over 2 million patients annually. Data shows that specialists like Prof. Dan Grisaro or Dr Shira Felder often hold dual training from prestigious North American institutions. This ensures patients receive treatment protocols aligned with the latest global oncology standards.
Patient Consensus: Patients value the speed of Israeli hospitals in transitioning from initial diagnostics to surgery. They recommend choosing tertiary academic hospitals for complex cervical cases to access coordinated radiation and chemotherapy under one roof.